CNSX - New Listing - Gemoscan Canada Inc.

TORONTO, Oct. 21 /CNW/ - The common shares of Gemoscan Canada, Inc. have been approved for listing on CNSX. The Company has 17,440,404 shares outstanding with a public float of approximately 7.5 million shares.

Gemoscan owns and markets the Hemocode System, a well-being and lifestyle solution that with a simple blood test that detects and provides solutions for the treatment of food intolerances. The Hemocode System generates customer-specific reports and recipe books which are provided to the customer accompanied by feedback from a health care specialist.

Listing and disclosure documents for Gemoscan Canada, Inc. will be available in the CNSX Listings Disclosure Hall

Trading Date: Friday, October 22, 2010
Symbol: GES
CUSIP: 36866N 10 6
ISIN: CA 36866N 10 6 9

Applications are being accepted for Market Makers for "GES".

For further information:

If you have any questions or require further information please contact Radhika at [phone] X 2435 or E-mail: [e-mail]